NBTXR3 Activated by Radiotherapy for Patients With Advanced Cancers Treated With An Anti-PD-1 Therapy

Clinical trial NCT03589339 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT03589339
Sponsor: Nanobiotix
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Radiotherapy Immunotherapy Microsatellite Instability-High Solid Malignant Tumour Metastasis From Malignant Tumor of Liver Squamous Cell Carcinoma of Head and Neck Metastasis From Malignant Tumor of Cervix Metastatic Renal Cell Carcinoma Metastasis From Malignant Melanoma of Skin (Disorder)Metastatic Triple-Negative Breast Carcinoma Metastatic NSCLC Metastasis From Malignant Tumor of Bladder (Disorder)

Start date: 2019-01-16
Primary completion: 2027-04-30
Enrollment: 145

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.